Functional analysis of Caenorhabditis elegans glutamate receptor subunits by domain transplantation. 2003

Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
Department of Biochemistry I, Receptor Biochemistry, Ruhr University Bochum, Bochum D-44780, Germany.

Glutamate receptors are not only abundant and important mediators of fast excitatory synaptic transmission in vertebrates, but they also serve a similar function in invertebrates such as Drosophila and the nematode Caenorhabditis elegans. In C. elegans, an animal with only 302 neurons, 10 different glutamate receptor subunits have been identified and cloned. To study the ion channel properties of these receptor subunits, we recorded glutamate-gated currents from Xenopus oocytes that expressed either C. elegans glutamate receptor subunits or chimeric rat/C. elegans glutamate receptor subunits. The chimeras were constructed between the C. elegans glutamate receptor pore domains and either the rat kainate receptor subunit GluR6, the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunit GluR1, or the N-methyl-d-aspartate (NMDA) receptor subunit NMDAR1-1a. Although native subunits were nonfunctional, 9 of 10 ion pores were found to conduct current upon transplantation into rat receptor subunits. A provisional classification of the C. elegans glutamate receptor subunits was attempted based on functionality of the chimeras. C. elegans glutamate receptor ion pores, at a position homologous to a highly conserved site critical for ion permeation properties in vertebrate glutamate receptor pores, contain amino acids not found in vertebrate glutamate receptors. We show that the pore-constricting Q/R site, which in vertebrate receptors determines calcium permeability and rectification properties of the ion channel, in C. elegans can be occupied by other amino acids, including, surprisingly, lysine and proline, without loss of these properties.

UI MeSH Term Description Entries
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D007608 Kainic Acid (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. Digenic Acid,Kainate,Acid, Digenic,Acid, Kainic
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell

Related Publications

Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
May 2024, Epilepsia open,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
December 1997, Genomics,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
September 2012, Molecular pharmacology,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
May 1999, The European journal of neuroscience,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
January 2002, Biological chemistry,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
March 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
November 2006, Biochemical Society transactions,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
November 2015, Molecular and biochemical parasitology,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
January 2003, Neuro-Signals,
Nathalie Strutz-Seebohm, and Markus Werner, and David M Madsen, and Guiscard Seebohm, and Yi Zheng, and Craig S Walker, and Andres V Maricq, and Michael Hollmann
April 2001, Molecular and biochemical parasitology,
Copied contents to your clipboard!